Clinical orientation and thought on several problems in post-marketed reassessment of traditional Chinese medicine / 中国中药杂志
China Journal of Chinese Materia Medica
; (24): 2893-2897, 2011.
Article
em Zh
| WPRIM
| ID: wpr-293158
Biblioteca responsável:
WPRO
ABSTRACT
The post-marketed reassessment is an important link to ensure the safety and effectiveness of traditional chinese medicine. It is also the expansion and stretch of new drug evaluation. Through the systematic, standard, rigorous post-marketed reassessment, the enterprise can full access to drugs after listing the efficacy and safety information, evaluate the interests and risk of the drug and provide the scientific basis for the drug use. It can also provide timely, scientific technology basis for government health decisions, the enterprise marketing decision and public health security. This paper mainly discussed the thought on clinical orientation of traditional chinese medicine in the post-marketed reassessment and how to reach the goal through systematic consideration and overall plan.
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Vigilância de Produtos Comercializados
/
Medicina Tradicional Chinesa
Tipo de estudo:
Diagnostic_studies
/
Prognostic_studies
Limite:
Humans
Idioma:
Zh
Revista:
China Journal of Chinese Materia Medica
Ano de publicação:
2011
Tipo de documento:
Article